| abstract |
The present invention provides a novel compound of formula (I) and its pharmaceutically active salts and the compound and its pharmaceutically active salts as ligands for the melanocortin receptor and / or for the treatment of melanocortin-based diseases. Provide a way to use:n n n n n n n n Wherein X and Y are independently selected from O, N, S and (CH 2 ) n (where n is 0, 1, 2, 3, 4 or 5) or combinations thereof, and Branched chains may of course include alicyclic and heterocyclic groups, where Q is H or OH; R 1 and R 2 are the same or different and are hydrogen or selected from the residues of the aromatic groups listed in Table 1. |